Organizations Employees Board Members Grants Contractors Top Rankings Pricing

Stay updated on 990 organization compensation

© 2026 Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices

Employees Foundation for Angelman Syndrome Therapeutics Michele Golombuski

Michele Golombuski

Officer

Chief Development Officer at Foundation for Angelman Syndrome Therapeutics

Fiscal year ended December 31, 2024. Published on January 25, 2026.

$210,068

2024

Total compensation

Michele Golombuski has been listed as an employee of Foundation for Angelman Syndrome Therapeutics in Form 990 filings since fiscal year 2024.

Annual compensation details

$210,068

Chief Development Officer

2024

$211k org

40 hrs/wk

Total compensation by year

Compare the compensation of Michele Golombuski to:

2024

Other employees at Foundation for Angelman Syndrome Therapeutics

Chief Science Officer

$0 from org$509,945 from relatedNo other comp

Chief Operating Oficer

$286,130 from orgNo related compNo other comp

President and Chief Executive Officer

$245,000 from orgNo related compNo other comp

Chief Financial Officer

$232,568 from orgNo related compNo other comp

Loading rankings…

Loading related profiles…

Revisions to this profile

January 25, 2026:

2024 Foundation for Angelman Syndrome Therapeutics 990 published

Get an email update when compensation for Michele Golombuski is updated

Email address

Related Jobs

Powered by Talroo

Report a discrepancy →

Other people named Michele Golombuski

2024

Michele Golombuski

The Michael J Fox Foundation for Parkinson's Research